摘要:
The invention is in the domain of delivery of molecules to brain cells across the blood-brain barrier. The invention relates to a novel polypeptide-based carrier that allows the efficient delivery of an effector peptide, to neuron cells across the blood-brain barrier, and to methods for the production and testing of such carrier, including a model for testing the capacity of such molecule to cross the blood-brain barrier and / or the toxicity of molecules on the blood brain barrier and/or the capacity of molecules that have crossed to target human brain cells (e/g. neurons, astrocytes and microglial cells).
摘要:
The present invention relates to an oligopeptide and conjugates thereof. The present invention also relates to the use of these oligopeptide conjugates for treating or diagnosing disorders mediated by amyloid β deposits. Finally, the present invention also relates to a coupling method for obtaining oligopeptide coupled with a substance of interest (functional conjugates).
摘要:
The present invention provides novel antibodies recognizing the so-called "Strep-Tag II" peptide, to its preparation and to uses thereof. Anti-strep tag antibodies are useful for quick purification but also for sensitive detection and tight immobilization of Strep-Tag II fusion proteins.
摘要:
The invention is in the domain of delivery of molecules to brain cells across the blood-brain barrier. The invention relates to a novel polypeptide-based carrier that allows the efficient delivery of an effector peptide, to neuron cells across the blood-brain barrier, and to methods for the production and testing of such carrier, including a model for testing the capacity of such molecule to cross the blood-brain barrier and / or the toxicity of molecules on the blood brain barrier and/or the capacity of molecules that have crossed to target human brain cells (e/g. neurons, astrocytes and microglial cells).
摘要:
The present invention relates to variable domain of a camelid heavy-chain antibodies directed to amyloid β and conjugates thereof. The present invention also relates to the use of these antibody conjugates for treating or diagnosing disorders mediated by amyloid β deposits.
摘要:
The present invention relates to variable domains of a camelid heavy-chain antibodies directed against a phosphorylated tau protein and conjugates thereof. The present invention also relates to the use of these domains or conjugates for treating or diagnosing disorders mediated by neurofibrillary tangles, neuropil threads or dystrophic neurites, such as tauopathies.
摘要:
The present invention relates to antibodies or fragments thereof, such as variable domains of camelid heavy-chain antibodies, directed against Hepatitis C virus glycoprotein E2, and uses thereof for preparing therapeutic or diagnostic agents.
摘要:
The present invention relates to variable domains of camelid heavy-chain antibodies directed against a glial fibrillary acidic protein and uses thereof for preparing therapeutic or diagnostic agents.
摘要:
Use of camelid single-domain antibodies for detecting an oligomeric form of the amyloid β peptide 42 and their therapeutic and diagnostic applications.
摘要:
Use of a variable fragment of a camelid single-chain antibody (VHH antibody) for the preparation of a peptide vector for delivering a substance of interest across the blood-brain barrier.